Braden M Leonard - 07 Nov 2022 Form 4 Insider Report for Metacrine, Inc.

Role
10%+ Owner
Signature
Braden Michael Leonard
Issuer symbol
N/A
Transactions as of
07 Nov 2022
Net transactions value
+$68,074
Form type
4
Filing time
09 Nov 2022, 17:29:57 UTC
Previous filing
31 Oct 2022
Next filing
16 Nov 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MTCR Common Stock Purchase $52,346 +123,954 +2.2% $0.4223 5,848,649 07 Nov 2022 Holding of BML Investment Partners, L.P. F1, F2
transaction MTCR Common Stock Purchase $200 +500 +0.01% $0.4000 5,849,149 08 Nov 2022 Holding of BML Investment Partners, L.P. F1
transaction MTCR Common Stock Purchase $15,528 +39,816 +0.68% $0.3900 5,888,965 09 Nov 2022 Holding of BML Investment Partners, L.P. F1, F3
holding MTCR Common Stock 600,000 07 Nov 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 BML Capital Management, LLC ("BML Capital") serves as the general partner of BML Investment Partners, L.P., a Delaware limited partnership (the "Fund"), which is the direct owner of the subject shares. Mr. Leonard is the managing member of BML Capital, and exercises investment and voting control over the subject shares. Accordingly, shares owned directly by the Fund may be regarded as being beneficially owned by Mr. Leonard. Notwithstanding, Mr. Leonard disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.
F2 The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.407 to $0.43. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.
F3 The shares were purchased in multiple transactions at $0.39. Full information regarding the number of shares purchased can be furnished to the SEC staff upon request.